SAVE MONEY ON TRAVEL DEALS

However, the study published in the Journal of the American Medical Association, said a higher risk of death remains as the duration of HIV infection lengthens.

Krishnan Bhaskaran of the Medical Research Council Clinical Trials Unit, London, and colleagues evaluated changes in the excess mortality of HIV-infected people compared with expected mortality in the general uninfected population -- adjusting for duration of HIV infection.

Mortality following HIV seroconversion -- development of antibodies in blood serum as a result of infection -- in a large multinational collaboration of HIV seroconverter cohorts was compared with expected mortality, calculated by applying general population death rates matched on demographic factors.

Of 16,534 people with median duration of follow-up of 6.3 years, 2,571 people had died as of December 2006, compared with an estimated 235 deaths that would have been expected in a matched general population cohort.

 BREAKING STORIES

3 Chinese dairy firms apologize

Ballesteros says he has brain tumor

Bollywood's Bachchan hospitalized

Official: Russia has no melamine victims

N. Korea: Kim Jong Il makes troop visit

Plastic surgery makes advances in wartime

New law puts mental, physical ills on par

Cervical cancer shot gains acceptance

Study: Ginkgo can prevent stroke damage

WHO probes deadly mystery illness

Claim: Magic Johnson 'faked' AIDS

Exercise intervention helps with arthritis

WHO: Mental health stigma unfair

Bird flu survival tied to hands-on therapy

TV star to wed after getting cancer news

NSAIDs linked to lower breast cancer risk

Kids' asthma diagnosis can be a challenge

Herb may help curb bad breath

New procedure to correct sagging breasts

Why pizza may cause women pain, urination